{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:36:34Z","timestamp":1783647394814,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/25\/2012"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/25\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejphar.2023.176010","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:37:40Z","timestamp":1692963460000},"page":"176010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF"],"prefix":"10.1016","volume":"958","author":[{"given":"Balasubramaniyan","family":"Vairappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1936-1159","authenticated-orcid":false,"given":"Gavin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundhar","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176010_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.3140380","article-title":"I kappa B: a specific inhibitor of the NF- kappa B transcription factor","volume":"242","author":"Baeuerle","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.176010_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/VHRM.S3409","article-title":"Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study","volume":"5","author":"Baguet","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2023.176010_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20140654","article-title":"NOS1-derived nitric oxide promotes NF-kappaB transcriptional activity through inhibition of suppressor of cytokine signaling-1","volume":"212","author":"Baig","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.176010_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18094-3","article-title":"Post-transcriptional regulation of hepatic DDAH1 with TNF blockade leads to improved eNOS function and reduced portal pressure in cirrhotic rats","volume":"7","author":"Balasubramanian","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.176010_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jhep.2013.01.023","article-title":"Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure","volume":"58","author":"Balasubramaniyan","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib6","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1021\/bi800682k","article-title":"Dynamical characterization of the heme NO oxygen binding (HNOX) domain. Insight into soluble guanylate cyclase allosteric transition","volume":"47","author":"Capece","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2023.176010_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"64","author":"Cerini","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib8","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1074\/jbc.M116.742627","article-title":"Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling","volume":"292","author":"Chakraborty","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176010_bib9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2007.01.017","article-title":"AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers","volume":"46","author":"Debernardi-Venon","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1096\/fj.00-0078com","article-title":"NOSIP, a novel modulator of endothelial nitric oxide synthase activity","volume":"15","author":"Dedio","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ejphar.2023.176010_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2012.12.012","article-title":"Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats","volume":"58","author":"Di Pascoli","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0895-7061(00)00302-2","article-title":"Candesartan cilexetil and renal hemodynamics in hypertensive patients","volume":"13","author":"Fridman","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2023.176010_bib13","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/HJH.0b013e32834bbb30","article-title":"Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia","volume":"29","author":"Fu","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2023.176010_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.07.034","article-title":"Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"54","author":"Garcia-Caldero","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2012.09.010","article-title":"Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats","volume":"58","author":"Guillaume","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1743290","article-title":"Renal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with liver cirrhosis: a nationwide cohort study","volume":"2019","author":"Hsu","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ejphar.2023.176010_bib17","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1242\/jcs.02620","article-title":"NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS","volume":"118","author":"Icking","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2023.176010_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2023.176010_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176010_bib20","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1242\/jcs.01290","article-title":"The syndapin protein family: linking membrane trafficking with the cytoskeleton","volume":"117","author":"Kessels","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2023.176010_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/gast.2002.34212","article-title":"Distribution of the novel eNOS-interacting protein NOSIP in the liver, pancreas, and gastrointestinal tract of the rat","volume":"123","author":"Konig","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2023.176010_bib22","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/1078-0432.CCR-05-2213","article-title":"Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer","volume":"12","author":"Kosugi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.176010_bib23","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/HJH.0b013e3283314bc7","article-title":"Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes","volume":"27","author":"Larrayoz","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2023.176010_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.176010_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ajpath.2016.11.017","article-title":"Caveolin 1 and G-protein-coupled receptor Kinase-2 coregulate endothelial nitric oxide synthase activity in sinusoidal endothelial cells","volume":"187","author":"Liu","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2023.176010_bib26","doi-asserted-by":"crossref","first-page":"15583","DOI":"10.1074\/jbc.272.25.15583","article-title":"Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin","volume":"272","author":"Michel","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176010_bib27","doi-asserted-by":"crossref","first-page":"25907","DOI":"10.1074\/jbc.272.41.25907","article-title":"Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase","volume":"272","author":"Michel","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176010_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","article-title":"Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis","volume":"45","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.176010_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176010_bib31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.21905","article-title":"The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: the missing piece?","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.176010_bib32","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1053\/j.gastro.2006.12.035","article-title":"Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis","volume":"132","author":"Mookerjee","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2023.176010_bib33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/hr.2012.8","article-title":"Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study","volume":"35","author":"Rakugi","year":"2012","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2023.176010_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.176010_bib35","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1091\/mbc.e05-08-0709","article-title":"Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN","volume":"17","author":"Schilling","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2023.176010_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2005.04.005","article-title":"Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis","volume":"108","author":"Schulz","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2023.176010_bib37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s10620-006-9133-1","article-title":"Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis","volume":"52","author":"Tox","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2023.176010_bib38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/01.HYP.0000184197.11226.71","article-title":"Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies","volume":"46","author":"Tsukimori","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.176010_bib39","first-page":"159","article-title":"Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis","volume":"55","author":"Tuncer","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2023.176010_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","article-title":"Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress","volume":"7","author":"Vairappan","year":"2015","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2023.176010_bib41","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1007\/s12035-018-1389-x","article-title":"Resveratrol restores neuronal tight junction proteins through correction of ammonia and inflammation in CCl4-induced cirrhotic mice","volume":"56","author":"Vairappan","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.176010_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000078950","article-title":"Safety and tolerability of high-dose angiotensin receptor blocker therapy in patients with chronic kidney disease: a pilot study","volume":"24","author":"Weinberg","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2023.176010_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2004.12.041","article-title":"Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia","volume":"89","author":"Xiang","year":"2005","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ejphar.2023.176010_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/erc.12.34","article-title":"Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan","volume":"10","author":"Yasuno","year":"2012","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.ejphar.2023.176010_bib45","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1073\/pnas.252345399","article-title":"NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase","volume":"99","author":"Zimmermann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:18:12Z","timestamp":1757978292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923005228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"alternative-id":["S0014299923005228"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176010"}}